BioStratum, Inc. develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Its products include Pyridorin, a small molecule drug for the treatment of diabetic kidney disease; and pre-clinical compounds that treat diabetic complications and cancer. The company was founded in 1994 and is headquartered in Durham, North Carolina.

Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.

Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA.

Sichuan Medco Pharmaceutical Stock Co., Ltd. is a Chinese private company located in Shifang. The firm engages in production and marketing of medicines, raw drugs and nutritive healthy products.

Formycon GmbH is more than a regular CRO that provides formulation and analytical services to the biopharmaceutical industry. The complete analytical development chain – starting from protein characterization and comparability studies up to GMP Quality Control and stability testing of clinical study and market medication. The Formulation one-stop shop – Formycon covers pre-formulation, development of systemic and local, liquid, freeze-dried and sustained release drug product formulations, supply of pre-clinical studies and development of the manufacturing process.

Part of Sysmex Corp., International Reagents Corp. is a company headquartered in Kobe-shi, Japan, that manufactures reagents. On April 01, 2002 Sysmex Corp. acquired International Reagents Corp.

Denka Seiken started out as a manufacturer of vaccines for human use. Later, they became involved with diagnostic reagents and expanded the scope of their business activities to meet the needs of their customers, offering product lines, service, and knowledge to hospitals and clinics. Denka Seiken has established itself as a manufacturer of vaccines and diagnostic reagents.\nDenka Seiken is engaged in research and development in such fields as bacteriology and virology, immunochemistry, clinical chemistry and food-related diagnostic reagents, in addition to vaccines against influenza, DPT, and other illnesses.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Henan Zhongli Biotechnology Co., Ltd., established on 2017-01-24, Business scope includes biotechnology development,technical consulting,technology transfer,Technical Services;Production, processing and sales:Pre-packaged food,Class I medical device,Class II medical device,Healthy food,primary agricultural products,medicine,cosmetic,plaster,Disinfectant;Import and export of goods or technology.

Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science.

Shandong Boyuan Biopharmaceutical Co., Ltd., established on 2018-09-20, Business scope includes drug research technology development,technical consulting,technology transfer,Technical extension services;Technology development of health products,technical consulting,technology transfer,Technical extension services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Purespring Therapeutics is an AAV gene therapy company focused on the kidney globally.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Nippon Kayaku produces and retails a range of chemicals. By product category, the company divides itself into four areas. Epoxy resins used as flame retardants in electronics, colorants, and dyes used in inkjet printers and materials for the production of textiles are sold by the functional chemicals segment, which is the one that generates the most income of any segment. Pharmaceutical companies market anti-cancer, biological, cardiovascular, vitamin, and anti-inflammatory medications. The automotive sector is supplied by the safety systems segment with airbag inflators and micro gas generators for seatbelt pre-tensioners, both of which are intended to protect passengers in the event of an accident. Insecticides and herbicides are offered for sale in the agrochemicals market.